Current Pharmaceutical Design

Papers
(The H4-Index of Current Pharmaceutical Design is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Preventive and Therapeutic Strategies to Fight COVID-1973
The Therapeutic Potential of Targeting the Angiotensin Pathway as a Novel Therapeutic Approach to Ameliorating Post-surgical Adhesions62
Synthetic Cannabinoids are Genotoxic in Cultured Human Lymphocytes46
Identification of Ferroptosis-related Genes for Diabetic Nephropathy by Bioinformatics and Experimental Validation44
Fabrication of Mastic Gum Resin Tethered Phospholipid Nanocarriers for the Evaluation and Enhancement of Anti-inflammatory and Anti-bacterial Effects42
Production, Characterization, and Molecular Dynamic Study of Antidiabetic and Antioxidative Peptides of Fermented Cheese Whey with Anti-inflammatory Properties using Limosilactobacillus fermentum42
Salivary Antiviral and Antibacterial Properties in the Encounter of SARS-CoV-242
Coptis chinensis Franch Relies on Berberine to Alleviate Stomach Heat Syndrome through the JAK2-STAT3-NF-κB Signaling Pathway and Amino Acid Metabolism Regulation41
Recent Advancement in Drug Targeting Therapies in the Treatment of Pancreatic Cancer40
Acknowledgements to Reviewers38
Establishment of an Integrated Population Pharmacokinetic/ Pharmacodynamics Model of Apixaban in Chinese Healthy Population Adjusting for Key Genetic Variants37
Leveraging AI and Natural Compounds: Innovative Approaches in the Diagnosis and Treatment of Hepatocellular Carcinoma35
Nutraceutical Interventions for Mitigating Skin Ageing: Analysis of Mechanisms and Efficacy33
The Molecular Mechanisms of Natural Medicinal Active Ingredients Interfering with Male Fertility33
Isorhynchophylline Regulates the Circadian Rhythm of the Hypothalamus in Spontaneously Hypertensive Rats to Treat Hypertension32
Stimuli-responsive Polymeric Nanosystems for Therapeutic Applications32
Astragaloside IV Protects Sepsis-induced Acute Kidney Injury by Attenuating Mitochondrial Dysfunction and Apoptosis in Renal Tubular Epithelial Cells32
Nanotheranostics for Diagnosis and Treatment of Breast Cancer32
CRISPR and Gene Editing: A Game-changer in Drug Development31
GnRH in the Treatment of Hypogonadotropic Hypogonadism31
RNA Aptamer-functionalized Polymeric Nanoparticles in Targeted Delivery and Cancer Therapy: An up-to-date Review30
Biosynthesis and Bioapplications of Nanomaterials from Mushroom Products30
Design, Synthesis, Molecular Docking, Dynamics and in vitro Evaluation of Novel 2-substituted-1-hydroxyethane-1, 1-bis(phosphonic acid) Derivatives as Human Farnesyl Pyrophosphate Synthase Inhibitors 29
PCSK9 Inhibitors for the Management of Dyslipidemia in People with Type 2 Diabetes: How Low is Too Low?29
Withdrawn: Specialized Pro-resolving Lipid Mediators: Endogenous Regulation of Vascular Inflammation and Remodeling28
Tablet Formulation of a Synthesized Celecoxib Potassium Salt and Development of a Validated Method for Its Analysis28
Preparation and Characterization of PLGA-based Magnetic Polymer Nanoparticles for Targeting Pancreatic Adenocarcinoma27
Neurodegenerative Diseases: A Multidisciplinary Approach27
0.088980197906494